id,disease_progression_status,survival_status,clinical_response_rate_target_lasion,clinical_response_rate_non_target_lasion,clinical_response_rate_new_lasion,clinical_response_rate_result,radiological_response_rate_target_lasion,radiological_response_rate_non_target_lasion,radiological_response_rate_new_lasion,radiological_response_rate_result,pathological_response_rate_target_lasion,pathological_response_rate_non_target_lasion,pathological_response_rate_new_lasion,pathological_response_rate_result,time,registration_number,laterality,current_chemo_protocol,chemo_starting_date,chemo_cycle_no,chemo_detail,disease_progression_status_date,pfs,survival_status_date,overall_survival,clinical_response_rate_date,radiological_response_rate_date,pathological_response_rate_date,cancer_type,patient_id_id,patient_id_socio_economic_status_name,patient_id_unique_id,patient_id_name,patient_id_phone,patient_id_date_of_birth,patient_id_gender,patient_id_blood_group,patient_id_area,patient_id_police_station,patient_id_district,doctor_id_name,center_id_name,grade_name,line_of_treatment_name,diagnosis_disease_group_name,diagnosis_subgroup_diagnosis_disease_group_name,diagnosis_subgroup_name,diagnosis_primary_site_name,diagnosis_laterility_name,patient_id_socio_economic_status,grade,disease_progression_status_name,survival_status_name,clinical_response_rate_target_lasion_name,clinical_response_rate_non_target_lasion_name,clinical_response_rate_new_lasion_name,clinical_response_rate_result_name,radiological_response_rate_target_lasion_name,radiological_response_rate_non_target_lasion_name,radiological_response_rate_new_lasion_name,radiological_response_rate_result_name,diagnosis_laterility,line_of_treatment,diagnosis_subgroup,pathological_response_rate_target_lasion_name,pathological_response_rate_non_target_lasion_name,pathological_response_rate_new_lasion_name,pathological_response_rate_result_name,diagnosis_disease_group,diagnosis_primary_site,name,value,unit,date,patient_observation_id
5,,,,,,,,,,,,,,,2024-03-28T17:47:49+06:00,BSH - H12110197955,Left,o Palbociclib + Letrozole + Zoladex 3.6mg C1 started from 29.09.2022,2022-09-29,,"Started palliative ChT with AC + Zoledronic C1 from 14.10.2021, 7 cycles Paclitaxel up to 16.02.2022 the
reviewed from TATA Mumbai.
Tab Tamoxifan 20 mg upto Sep 2022> PD in neck nodes & Marker",2024-03-28,,2024-03-28,,2024-03-28,2024-03-28,,Breast,5,,BSBSC-240000005,FATEMA BAGUM,1917821797,1962-02-08,Female,,,,,Dr Md Arifur Rahman,BSH,,2nd Line,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,C50.4- Upper-outer quadrant of breast,Breast,Left,,,Progressed,Alive,PD,Non-PD,No,PD,PD,Non-PD,Yes,PR,,,,,,,,,,,,,,
62,,,,,,,,,,,,,,,2024-05-06T18:27:07+06:00,BSH - H12202230745,,Zoclast,2023-01-03,3.0,"On Abemaciclib/ Letrozole/ CCM/ Osteophos since since July 2022
Inj Zoclast 4mg, C1 started on March 2023, 6 monthly, Next C3 due on 24.03.24",2024-03-25,,2024-03-28,,,,,Breast,5,,BSBSC-240000005,FATEMA BAGUM,1917821797,1962-02-08,Female,,,,,Dr Md Arifur Rahman,BSH,2.0,2nd Line,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,C50.5- Lower-outer quadrant of breast,Breast,Left,,,Stable,Alive,,,,,,,,,,,,,,,,,,,,,,
